68 results
8-K
EX-99.1
MRZM
Marizyme, Inc.
13 Oct 20
Other Events
11:04am
developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications. Today … and bypass grafting, the free graft is stored in saline or autologous blood which does not protect the graft from ischemic injury thereby increasing
8-K
MRZM
Marizyme, Inc.
5 Jun 20
Entry into a Material Definitive Agreement
4:01pm
is engaged in developing products to prevent ischemic injury to organs and tissues and itsproducts (the “SomahProducts”) include DuraGraft, aone-time … in developing products to prevent ischemic injury to organs and tissues and its products, which we refer to as the Somah Products, include DuraGraft
8-K
EX-99.1
ria32vkm
5 Jan 22
Marizyme Announces Allowance of Patent Application for Flagship Product
4:33pm
8-K
l6vgf5y bcwvqz4zp
19 Dec 19
Entry into a Material Definitive Agreement
4:23pm
8-K
i0t3bxdl vbqh
5 Aug 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-99.1.1
1971fo8h
29 Sep 20
Marizyme, Inc. Completes Acquisition of Somahlution, Inc. and Raises $7.0 Million in Private Placement
1:58pm
8-K
EX-99.2
jvoe1ds
6 Nov 20
Executive Employment Agreement
12:00am
8-K
EX-99.2
b43ci
10 May 23
Marizyme Announces IP Developments for DuraGraft® and its Pipeline Products
8:30am
8-K
EX-99.1
r9wl2 bgbgbcrwsc
31 Mar 21
Marizyme, Inc. Issues Letter to Shareholders
10:00am